| (USD) | Sep 2023 | Y/Y change |
|---|---|---|
| Revenue | 417.00K | — |
| Operating expense | — | — |
| Net income | -83.00K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ARDS returned +0.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -93.3% |
| 1 year | +0.0% |
| 5 years | -100.0% |
| All-time high | $13.45 (Aug 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ARDS would be worth today ›No. Aridis Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Aridis Pharmaceuticals, Inc. is part of the Healthcare sector.
Aridis Pharmaceuticals, Inc. has a market cap of 4.46K USD, based on the latest quote.
